Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Cobbe, S.M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cobbe, S.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


How best to combat the enemies? Lipid lowering

S.M. Cobbe*

Department of Medical Cardiology, Glasgow Royal Infirmary, University of Glasgow, Glasgow, U.K.

* Correspondence: Stuart M. Cobbe, MD FRCP, Department of Medical Cardiology, Glasgow Royal Infirmary, 10 Alexandra Parade, Glasgow, G31 2ER, U.K.

Abstract

The evidence linking elevated plasma low-density lipoprotein cholesterol to atherosclerosis and its clinical consequences is overwhelming. Similarly, there is now compelling evidence that the risk of these complications can be reduced by lipid-lowering therapies. Research reported during the past few years has helped to clarify the apparent paradox of substantial reductions in the risk for cardiovascular events in the presence of minor changes in the extent of coronary artery stenosis. It is clear that lipid reduction results in favourable changes in plaque morphology and composition, reflecting a reduction in the inflammatory content and an increase in the smooth muscle content that favour stability. In addition, changes in endothelial function, platelet adhesiveness and rheology all potentially play a role in the beneficial effects of lipid lowering.

Key Words: Atherosclerosis • lipid lowering • plaque stability


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Clin PharmacolHome page
A. Meaney, G. Ceballos, J. Asbun, G. Solache, E. Mendoza, A. Vela, and E. Meaney
The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study
J. Clin. Pharmacol., July 1, 2009; 49(7): 838 - 847.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.